about
Variable abnormal physiological motility in the proximal upper gastrointestinal tract in gastroparesis.Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.Opioids and GI Motility-Friend or Foe?Sugars, Sweet Taste Receptors, and Brain Responses.The role of preoperative high resolution manometry in predicting dysphagia after laparoscopic Nissen fundoplication.In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs.Altered Intestinal Microbiota with Increased Abundance of Prevotella Is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome.Linking the Gastrointestinal Behavior of Ibuprofen with The Systemic Exposure Between and Within Humans - Part 1: Fasted StateThe impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trialGeneralized transit delay on wireless motility capsule testing in patients with clinical suspicion of gastroparesis, small intestinal dysmotility, or slow transit constipationAn unusual cause of upper gastrointestinal bleedingG-POEM for Gastroparesis: Is There Pressure to Go with the Flow?Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: A multi-compartment stomach approachLactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoidsFusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State
P50
Q36037291-028ECDAB-60B6-47A4-AFAC-AA2493738027Q38645247-73D6471A-B780-4798-9A26-AF594DA65926Q38997203-64736422-6AAD-4179-87BA-26B76B615F22Q39411595-6B73EB69-F078-439E-873A-24ABCC623E08Q47194477-BEA9C342-20B1-4732-8F68-E49DCC3D599FQ47875578-55640EF3-37E5-42A3-B619-543937A815FBQ47888842-05B29430-8E9C-4AA5-85D6-E647C2ACF4B0Q55394076-89B1D17F-2CCD-4196-8A6F-5221AF5A4C09Q58105559-02A3C969-EB7A-4842-AB67-81BF6CCBA593Q58710660-32553E90-71F9-4B42-B72E-894896BD9B40Q84229759-ED44FCFD-21E8-4C47-958D-EDB9827E1F3CQ87618086-47B101E4-A82A-4687-BC9B-082EEB986769Q88946001-2016B388-C532-4F2A-8E28-62FAD441F166Q88950865-1F7E7164-75A6-4FFF-A672-93A14FC9059DQ90441011-321E4164-EB18-4ED4-A865-803361E03CC8Q92475045-2F6CF6DC-0A2B-458F-B48A-A9FDC75ABEBAQ92996835-111DB950-000B-4B07-A60A-CA18AC9FB94B
P50
description
researcher (ORCID 0000-0002-4861-7646)
@en
name
A Lee
@en
type
label
A Lee
@en
prefLabel
A Lee
@en
P31
P496
0000-0002-4861-7646